Anti-NAGPA monoclonal antibody

Pre-made anti-NAGPA monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to NAGPA/NAGPA products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP1233-Ab-1/ GM-Tg-hg-IP1233-Ab-2Anti-Human NAGPA monoclonal antibodyHuman
GM-Tg-rg-IP1233-Ab-1/ GM-Tg-rg-IP1233-Ab-2Anti-Rat NAGPA monoclonal antibodyRat
GM-Tg-mg-IP1233-Ab-1/ GM-Tg-mg-IP1233-Ab-2Anti-Mouse NAGPA monoclonal antibodyMouse
GM-Tg-cynog-IP1233-Ab-1/ GM-Tg-cynog-IP1233-Ab-2Anti-Cynomolgus/ Rhesus macaque NAGPA monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP1233-Ab-1/ GM-Tg-felg-IP1233-Ab-2Anti-Feline NAGPA monoclonal antibodyFeline
GM-Tg-cang-IP1233-Ab-1/ GM-Tg-cang-IP1233-Ab-2Anti-Canine NAGPA monoclonal antibodyCanine
GM-Tg-bovg-IP1233-Ab-1/ GM-Tg-bovg-IP1233-Ab-2Anti-Bovine NAGPA monoclonal antibodyBovine
GM-Tg-equg-IP1233-Ab-1/ GM-Tg-equg-IP1233-Ab-2Anti-Equine NAGPA monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP1233-Ab-1/ GM-Tg-hg-IP1233-Ab-2; GM-Tg-rg-IP1233-Ab-1/ GM-Tg-rg-IP1233-Ab-2;
GM-Tg-mg-IP1233-Ab-1/ GM-Tg-mg-IP1233-Ab-2; GM-Tg-cynog-IP1233-Ab-1/ GM-Tg-cynog-IP1233-Ab-2;
GM-Tg-felg-IP1233-Ab-1/ GM-Tg-felg-IP1233-Ab-2; GM-Tg-cang-IP1233-Ab-1/ GM-Tg-cang-IP1233-Ab-2;
GM-Tg-bovg-IP1233-Ab-1/ GM-Tg-bovg-IP1233-Ab-2; GM-Tg-equg-IP1233-Ab-1/ GM-Tg-equg-IP1233-Ab-2
Products NameAnti-NAGPA monoclonal antibody
Formatmab
Target NameNAGPA
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-NAGPA monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP1233-Ag-1Recombinant multi-species NAGPA/ APAA/ UCE protein


    Target information

    Target IDGM-IP1233
    Target NameNAGPA
    Gene ID51172,27426,360476,707352,490019,101091582,515935,100069983
    Gene Symbol and SynonymsAPAA,NAGPA,UCE
    Uniprot AccessionQ9UK23,P68827
    Uniprot Entry NameNAGPA_HUMAN,NAGPA_BOVIN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000103174
    Target ClassificationN/A

    The target: NAGPA, gene name: NAGPA, also named as APAA, UCE. Hydrolases are transported to lysosomes after binding to mannose 6-phosphate receptors in the trans-Golgi network. This gene encodes the enzyme that catalyzes the second step in the formation of the mannose 6-phosphate recognition marker on lysosomal hydrolases. Commonly known as 'uncovering enzyme' or UCE, this enzyme removes N-acetyl-D-glucosamine (GlcNAc) residues from GlcNAc-alpha-P-mannose moieties and thereby produces the recognition marker. The encoded preproprotein is proteolytically processed by furin to generate the mature enzyme, a homotetramer of two disulfide-linked homodimers. Mutations in this gene are associated with developmental stuttering in human patients. [provided by RefSeq, Oct 2015].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.